UNIVERSITY CLINICAL CENTER PROF. K. GIBIŃSKI MEDICAL UNIVERSITY OF SILESIA IN KATOWICE has floated a tender for Delivery of Medicinal Products. The project location is Poland and the tender is closing on 25 Mar 2024. The tender notice number is 110414-2024, while the TOT Ref Number is 97372838. Bidders can have further information about the Tender and can request the complete Tender document by Registering on the site.

Expired Tender

Procurement Summary

Country : Poland

Summary : Delivery of Medicinal Products

Deadline : 25 Mar 2024

Other Information

Notice Type : Tender

TOT Ref.No.: 97372838

Document Ref. No. : 110414-2024

Competition : ICB

Financier : Self Financed

Purchaser Ownership : Public

Tender Value : Refer Document

Purchaser's Detail

Name :Login to see tender_details

Address : Login to see tender_details

Email : Login to see tender_details

Login to see details

Tender Details

Delivery of medicinal products divided into 33 parts

Part 1 - Formulated substances

Part 1 - Formulated substances - specification and quantitative assortment specified in Annex 4.1 SWZ

Part 2 - Immunoglobulin 1

Part 2 - Immunoglobulin I - specification and quantitative assortment specifiedincluded in Annex 4.2 SWZ

Part 3 - Trabectedin

Part 3 - Trabectedin - specification and quantitative specification are specified in Annex 4.3 SWZ

Part 4 - Bevacizumab

Part 4 - Bevacizumab - specification and quantitative specification are specified in Annex 4.4 SWZ

Part 5 - Lanreotide

Part 5 - Lanreotide - product and quantity specification is specified in Annex 4.5 SWZ

Part 6 - Aflibercept

Part 6 - Aflibercept - product and quantity specification is specified in Annex 4.6 SWZ

Part 7 - Dexamethasonum

Part 7 - Dexamethasonum - product and quantity specification okare specified in Annex 4.7 SWZ

Part 8 - Pasireotide

Part 8 - Pasireotide - specification and quantitative specification are specified in Annex 4.8 SWZ

Part 9 - Miscellaneous drugs

Part 9 - Miscellaneous drugs - specification and quantitative assortment are specified in Annex 4.9 SWZ

Part 10 - Immunoglobulinm II

Part 10 - Immunoglobulinum II - product and quantity specification specified in Annex 4.10 SWZ

Part 11 - Propofolum

Part 11 - Propofolum - product and quantitative specification specified in Annex 4.11 SWZ

Part 12 - Botulinum toxin A

Part 12 - Botulinum toxin...
Document Type: Contract Notice
Reference Number: DZP.281.12A.2024
Contract Type: supplies
Authority Type: body-pl
Doc Title: Dostawa produktow leczniczych
Dispatch Date: 2024-02-21
Publish Date: 2024-02-22
Submission Date: 2024-03-25

Documents

 Tender Notice